睡眠障碍市场规模、份额和成长分析（按障碍类型、产品、最终用途和地区）- 2025-2032 年产业预测

2023 年睡眠障碍市场规模价值 276 亿美元，预计将从 2024 年的 303.9 亿美元成长到 2032 年的 656.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 10.1%。

全球睡眠障碍市场专注于睡眠相关障碍的诊断、治疗和管理，由于人们越来越意识到睡眠对整体健康的重要性，该市场正在经历显着增长。由于压力和生活方式的改变，失眠、睡眠呼吸中止症和不安腿症候群等各种疾病变得越来越普遍。创新诊断工具和远端医疗解决方案等技术进步也在推动市场扩张。此外，人口老化以及肥胖症和糖尿病等慢性病发病率的上升也导致对有效干预措施的需求日益增加。因此，製药和医疗设备公司正在大力投资研发，以提供更好的治疗方法和解决方案，随着人们越来越意识到睡眠在健康中的关键作用，市场肯定会继续保持上升势头。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

睡眠障碍市场规模（依障碍类型和复合年增长率） (2025-2032)

• 市场概况
• 失眠
• 睡眠呼吸中止症
• 不安腿综合症
• 嗜睡症
• 昼夜节律紊乱

睡眠障碍市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 诊断
• 治疗

睡眠障碍市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概况
• 医院及睡眠实验室
• 居家照护机构及个人

睡眠障碍市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Merck & Co., Inc.（USA）
• Mylan NV（USA）
• Pfizer Inc.（USA）
• Takeda Pharmaceutical Company Limited（Japan）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Jazz Pharmaceuticals plc（Ireland）
• Sanofi（France）
• GlaxoSmithKline plc（UK）
• Eli Lilly and Company（USA）
• Becton, Dickinson and Company（USA）
• Koninklijke Philips NV（Netherlands）
• ResMed Inc.（USA）
• Fisher & Paykel Healthcare Corporation Limited（New Zealand）
• Natus Medical Incorporated（USA）
• Compumedics Limited（Australia）
• Vyaire Medical, Inc.（USA）
• SomnoMed Limited（Australia）
• Drive DeVilbiss Healthcare（USA）
• Cadwell Industries, Inc.（USA）

结论和建议

Sleep Disorder Market size was valued at USD 27.6 billion in 2023 and is poised to grow from USD 30.39 billion in 2024 to USD 65.61 billion by 2032, growing at a CAGR of 10.1% during the forecast period (2025-2032).

The Global Sleep Disorder Market, focused on diagnosing, treating, and managing sleep-related conditions, is experiencing significant growth due to heightened awareness of the importance of sleep for overall health. Various disorders such as insomnia, sleep apnea, and restless legs syndrome are becoming increasingly prevalent due to stress and changing lifestyles. Technological advancements, including innovative diagnostic tools and telemedicine solutions, are also driving market expansion. Additionally, the aging population and rising rates of obesity and chronic conditions like diabetes contribute to the growing demand for effective interventions. As a result, pharmaceutical companies and medical device manufacturers are heavily investing in research and development to deliver enhanced therapies and solutions, ensuring the market's upward momentum continues in response to the growing recognition of sleep's vital role in health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sleep Disorder market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sleep Disorder Market Segments Analysis

Global Sleep Disorder Market is segmented by Disorder Type, Product, End-use and region. Based on Disorder Type, the market is segmented into Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy and Circadian Rhythm Disorders. Based on Product, the market is segmented into Diagnostics and Therapeutics. Based on End-use, the market is segmented into Hospitals & Sleep Laboratories and Home Care Settings & Individuals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sleep Disorder Market

An important catalyst for the growth of the sleep disorder market is the rising awareness regarding the detrimental health effects associated with these conditions. As education and information are circulated through numerous platforms, a significant number of individuals are becoming more informed about the importance of addressing sleep-related concerns. This heightened awareness encourages people to pursue proper diagnosis and treatment, leading to an increased demand for sleep disorder solutions. Consequently, as the public becomes more cognizant of how sleep disorders can affect overall health and quality of life, the market for effective treatments and interventions is expected to expand.

Restraints in the Sleep Disorder Market

The sleep disorder market faces significant restraints due to the persistent stigma surrounding these conditions, which discourages many individuals from pursuing professional assistance. This societal perception can result in delayed treatment and worsening symptoms. Furthermore, in various regions, a general lack of awareness about sleep disorders impedes timely diagnosis and intervention, leaving many sufferers without the help they need. This combination of stigma and insufficient awareness not only affects individual health outcomes but also poses challenges for the overall growth of the sleep disorder market, as potential patients may remain unaware of the resources and support available to them.

Market Trends of the Sleep Disorder Market

The sleep disorder market is experiencing a significant trend toward telemedicine and remote monitoring, driven largely by the COVID-19 pandemic. Consumers are increasingly seeking convenient access to sleep disorder diagnosis and treatment, leading to the emergence of virtual sleep clinics and advanced wearable technologies that facilitate real-time sleep tracking from home. This shift not only enhances patient engagement but also reduces barriers to care, making it easier for individuals to seek help. As awareness of sleep disorders grows, along with the demand for personalized and accessible healthcare solutions, the market is projected to expand rapidly, reinforcing the critical role of technology in sleep health management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Sleep Disorder Market Size by Disorder Type & CAGR (2025-2032)

• Market Overview
• Insomnia
• Sleep Apnea
• Restless Legs Syndrome
• Narcolepsy
• Circadian Rhythm Disorders

Global Sleep Disorder Market Size by Product & CAGR (2025-2032)

• Market Overview
• Diagnostics
• Therapeutics

Global Sleep Disorder Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals & Sleep Laboratories
• Home Care Settings & Individuals

Global Sleep Disorder Market Size & CAGR (2025-2032)

• North America (Disorder Type, Product, End-use)
  • US
  • Canada
• Europe (Disorder Type, Product, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disorder Type, Product, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disorder Type, Product, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disorder Type, Product, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jazz Pharmaceuticals plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare Corporation Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compumedics Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SomnoMed Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drive DeVilbiss Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadwell Industries, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations